Teprenone
PreclinicalSmall molecule
EisaiTeprenone is one of 2 small molecule programs targeting Hematopoietic Stem Cell Transplantation (HSCT). It is currently in Preclinical.
1
Indications
2
Total Trials
1
Active Trials
1
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
5 competitors in Hematopoietic Stem Cell Transplantation (HSCT)
#DrugCompanyPhaseTrials
1Nexium
DDexcel Pharma Technologies Ltd.
Preclinical
Teprenone
EisaiPreclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Teprenone. EMBL-EBI & Wellcome Sanger Institute.
- [4]